MSB 8.42% $1.03 mesoblast limited

update on Novartis deal closing, confirmation aGvHD denial on...

  1. 156 Posts.
    lightbulb Created with Sketch. 17
    update on Novartis deal closing, confirmation aGvHD denial on accelerated approval and their next step, update on CLBP trial and next steps and lastly Si stepping down replaced by Fred Grossnan in the new year.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.